Calphostin C triggers calcium-dependent apoptosis in human acute lymphoblastic leukemia cells

Clinical Cancer Research

Volumn 4, Issue 12, 1998, Pages 2967-2976

  Zhu, De Min ^a   Narla, Rama Krishna ^a,b   Fang, Wei Hua ^a   Chia, Nian Cherng ^a   Uckun, Fatih M ^a,b  

^a Parker Hughes Cancer Center   (United States)

^b PARKER HUGHES INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALPHOSTIN C;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; DAUDI CELL; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TARGET CELL DESTRUCTION;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BIOLOGICAL TRANSPORT; CALCIUM SIGNALING; CELL DIVISION; CELL LINE; CHILD; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LYMPHOMA, B-CELL; NAPHTHALENES; TUMOR CELLS, CULTURED;

EID: 0032435749     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Uckun, F. M., Nachman, J. B., Sather, H. N., Sensel, M. G., Theil, K., Kraft, P., Steinherz, P. G., Lange, B., Hutchinson, R., Reaman, G. H., Gaynon, P. S., and Heerema, N. A. Clinical significance of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group. Cancer (Phila.), 83: 2030-2039, 1998.
2. Reaman, G. H., Sposto, R., Sensel, M. G., Lange, B. J., Feusner, J., Heerema, N. A., Leonard, M., Holmes, E., Sather, H. N., Pendergrass, T., Johnstone, H., O'Brien, R., Steinherz, P. G., Zeltzer, P., Gaynon, P. S., Trigg, M., and Uckun, F. M. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on consecutive trials of the Children's Cancer Group. J. Clin. Oncol.; in press, 1998.
3. Uckun, F. M., Sensel, M. G., Sather, H. N., Gaynon, P. S., Arthur, D. C., Lange, B. J., Steinherz, P. G., Kraft, P., Hutchinson, R., Nachman, J. B., Reaman, G. H., and Heerema, N. A. Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: report from the Children's Cancer Group. J. Clin. Oncol., 16: 527-535, 1998.
4. Uckun, F. M., Sensel, M. G., Waddick, K. G., Steinherz, P. G., Trigg, M. E., Heerema, N. A., Sather, H. N., Reaman, G. H., and Gaynon, P. S. Biology and treatment of childhood T-lineage acute lymphoblastic leukemia. Blood, 91: 735-746, 1998.
5. Gaynon, P. S., Desai, A., Bostrom, B. C., Hutchinson, R., Nachman, J. B., Reaman, G. H., Sather, H. N., Steinherz, P. G., Trigg, M. E., Tubergen, D. G., and Uckun, F. M. Early response to therapy and outcome in childhood acute lymphoblastic leukemia. Cancer (Phila.), 80: 1717-1726, 1997.
6. Trigg, M. E., Gaynon, P. S., and Uckun, F. M. Acute lymphoblastic leukemfa in children. In: J. F. Holland, E. Fry III, R. C. Bast, Jr., D. W. Kufe, D. L. Morton, R. R. Weichselbaum (eds.), Cancer Medicine, 4th ed., pp. 2945-2960. Baltimore: Williams and Wilkins, 1996.
7. Kobayashi, E., Nakan, H., Morimoto, M., and Tamaoki, T. Calphostin C (UCN-1028 C), a novel microbial compound, is a highly potent and specific inhibitor of protein Kinase C. Biochem. Biophys. Res. Commun., 159: 548-553, 1989.
8. Kobayashi, E., Ando, K., Nakano, H., Iida, T., Ohno, H., Morimoto, M., and Tamaoki, T. Calphostin (UCN-1028), novel and specific inhibitors of protein Kinase C. I. Fermentation, isolation, physico-chemical properties and biological activities. J. Antibiot. (Tokyo), 42: 1470-1474, 1989.
9. Gamou, S., and Shimizu, N. Calphostin C stimulates epidermal growth factor receptor phosphorylation and internalization via light-dependent mechanism. J. Cell. Physiol., 158: 151-159, 1994.
10. Fabbri, M., Bannykh, S., and Batch, W. E. Export of protein from the endoplasmic reticulum is regulated by a diacylglycerol/phorbol ester binding protein. J. Biol. Chem., 269: 26848-26857, 1994.
11. Gupta, S., Patel, K., Singh, H., and Gollapudi, S. Effect of calphostin C on daunorubicin resistance in P388/ADR and HL60/AR cells: reversal of drug resistance possible via P-glycoprotein. Cancer Lett., 30: 139-145, 1994.
12. Svetlov, S., and Nigam, S. Calphostin C, a specific protein kinase C inhibitor, activates human neutrophils: effect on phospholipase A2 and aggregation. Biochim. Biophys. Acta, 1177: 75-78, 1993.
13. Lee, S. C., and Yang, S. D. Calphostin C induces tyrosine dephosphorylation/inactivation of protein kinases FA/GSK-3 α in a pathway independent of tumor promoter phorbol ester-mediated down-regulation of protein kinase C. J. Cell. Biochem., 60: 121-129, 1996.
14. Wang, H. K., Xie, J. X., Chang, J. J., Hwang, K. M., Liu, S. Y., Ballas, L. M., Jiang, J. B., and Lee, K. H. Antitumor agents. 134. New shiraiachrome-A- and calphostin-C-related perylene derivatives as cytotoxic and antiviral agents and inhibitors of protein kinase C. J. Med. Chem., 35: 2717-2721, 1992.
15. Gopapakrishna, R., Chen, Z. H., and Gundimeda, U. Irreversible oxidativation of protein kinase C by photosensitive inhibitor calphostin C. FEBS Lett., 314: 149-154, 1992.
16. Dubyak, G. R., and Kertesy, S. B. Inhibition of GTP γ S-dependent phospholipase D and Rho membrane association by calphostin is independent of protein kinase C catalytic activity. Arch. Biochem. Biophys., 341: 129-139, 1997.
17. Rotenberg, S. A., Huang, M. H., Zhu, J., Su, L., and Riedel, H. Deletion analysis of protein kinase C inactivation by calphostin C. Mol. Carcinog., 12: 42-49, 1995.
18. Ikemoto, H., Tani, E., Matsumoto, T., Nakano, A., and Furuyama, J. Apoptosis of human glioma cells in response to calphostin C, a specific protein kinase C inhibitor. J. Neurosurg., 83: 1008-1016, 1995.